Titre : Visiteurs des patients

Visiteurs des patients : Questions médicales fréquentes

Termes MeSH sélectionnés :

Matrix Metalloproteinase 9

Questions fréquentes et termes MeSH associés

Diagnostic 2

#1

Comment évaluer l'impact des visites sur le patient ?

L'impact peut être évalué par des questionnaires sur le bien-être et l'état émotionnel.
Évaluation Bien-être Visiteurs
#2

Quels signes indiquent qu'un patient a besoin de visites ?

Un patient peut montrer des signes de solitude, d'anxiété ou de dépression.
Solitude Anxiété Dépression

Symptômes 2

#1

Quels symptômes peuvent s'aggraver sans visites ?

L'isolement social peut aggraver l'anxiété et la dépression chez le patient.
Isolement social Anxiété Dépression
#2

Les visites peuvent-elles réduire la douleur perçue ?

Oui, le soutien émotionnel des visiteurs peut diminuer la perception de la douleur.
Douleur Soutien émotionnel Visiteurs

Prévention 2

#1

Comment prévenir l'isolement des patients ?

Encourager les visites régulières et utiliser des technologies de communication.
Isolement Visites Technologie
#2

Quelles mesures prendre pour des visites sûres ?

Respecter les protocoles d'hygiène et les restrictions de visite en place.
Hygiène Protocoles Visiteurs

Traitements 2

#1

Les visites font-elles partie du traitement ?

Oui, les visites peuvent être considérées comme un complément au traitement médical.
Traitement Soutien social Visiteurs
#2

Comment les hôpitaux gèrent-ils les visites ?

Les hôpitaux établissent des horaires et des règles pour assurer la sécurité des patients.
Gestion des visites Sécurité Hôpital

Complications 2

#1

Quelles complications peuvent survenir sans visites ?

L'absence de visites peut entraîner une détérioration de la santé mentale et physique.
Complications Santé mentale Santé physique
#2

Les visites peuvent-elles causer du stress au patient ?

Oui, des visites non planifiées ou trop fréquentes peuvent causer du stress.
Stress Visiteurs Planification

Facteurs de risque 2

#1

Quels facteurs augmentent le besoin de visites ?

L'âge avancé, les maladies chroniques et l'isolement social augmentent ce besoin.
Âge avancé Maladies chroniques Isolement social
#2

Les patients en soins intensifs ont-ils plus besoin de visites ?

Oui, les patients en soins intensifs peuvent bénéficier davantage du soutien des visiteurs.
Soins intensifs Soutien Visiteurs
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Visiteurs des patients : Questions médicales les plus fréquentes", "headline": "Visiteurs des patients : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Visiteurs des patients : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-31", "dateModified": "2025-03-26", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Visiteurs des patients" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Personnes", "url": "https://questionsmedicales.fr/mesh/D009272", "about": { "@type": "MedicalCondition", "name": "Personnes", "code": { "@type": "MedicalCode", "code": "D009272", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "M01" } } }, "about": { "@type": "MedicalCondition", "name": "Visiteurs des patients", "alternateName": "Visitors to Patients", "code": { "@type": "MedicalCode", "code": "D014789", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Samantha J Chiew", "url": "https://questionsmedicales.fr/author/Samantha%20J%20Chiew", "affiliation": { "@type": "Organization", "name": "Animal Welfare Science Centre, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, North Melbourne, VIC, Australia." } }, { "@type": "Person", "name": "Paul H Hemsworth", "url": "https://questionsmedicales.fr/author/Paul%20H%20Hemsworth", "affiliation": { "@type": "Organization", "name": "Animal Welfare Science Centre, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, North Melbourne, VIC, Australia." } }, { "@type": "Person", "name": "Sally L Sherwen", "url": "https://questionsmedicales.fr/author/Sally%20L%20Sherwen", "affiliation": { "@type": "Organization", "name": "Department of Wildlife Conservation and Science, Zoos Victoria, Parkville, VIC, Australia." } }, { "@type": "Person", "name": "Grahame J Coleman", "url": "https://questionsmedicales.fr/author/Grahame%20J%20Coleman", "affiliation": { "@type": "Organization", "name": "Animal Welfare Science Centre, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, North Melbourne, VIC, Australia." } }, { "@type": "Person", "name": "Vicky Melfi", "url": "https://questionsmedicales.fr/author/Vicky%20Melfi", "affiliation": { "@type": "Organization", "name": "Hartpury University and Hartpury College, Gloucester, United Kingdom." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Tissue inhibitors of metalloproteinases are proteolytic targets of matrix metalloproteinase 9.", "datePublished": "2023-10-06", "url": "https://questionsmedicales.fr/article/37804930", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.matbio.2023.09.002" } }, { "@type": "ScholarlyArticle", "name": "Novel Matrix Metalloproteinase-9 (MMP-9) Inhibitors in Cancer Treatment.", "datePublished": "2023-07-28", "url": "https://questionsmedicales.fr/article/37569509", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijms241512133" } }, { "@type": "ScholarlyArticle", "name": "Prognostic value of matrix metalloproteinase-2 protein and matrix metalloproteinase-9 protein in colorectal cancer: a meta-analysis.", "datePublished": "2024-08-29", "url": "https://questionsmedicales.fr/article/39210344", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12885-024-12775-9" } }, { "@type": "ScholarlyArticle", "name": "Expression of laminin-1 and matrix metalloproteinase-9 in benign and malignant endometrium.", "datePublished": "2023-02-22", "url": "https://questionsmedicales.fr/article/36945954", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.55730/1300-0144.5568" } }, { "@type": "ScholarlyArticle", "name": "In Silico and In Vitro Approach for Validating the Inhibition of Matrix Metalloproteinase-9 by Quercetin.", "datePublished": "2023-03-13", "url": "https://questionsmedicales.fr/article/36912460", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/ICL.0000000000000982" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Personnes", "item": "https://questionsmedicales.fr/mesh/D009272" }, { "@type": "ListItem", "position": 3, "name": "Visiteurs des patients", "item": "https://questionsmedicales.fr/mesh/D014789" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Visiteurs des patients - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Visiteurs des patients", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Visiteurs des patients", "description": "Comment évaluer l'impact des visites sur le patient ?\nQuels signes indiquent qu'un patient a besoin de visites ?", "url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=Matrix+Metalloproteinase+9#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Visiteurs des patients", "description": "Quels symptômes peuvent s'aggraver sans visites ?\nLes visites peuvent-elles réduire la douleur perçue ?", "url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=Matrix+Metalloproteinase+9#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Visiteurs des patients", "description": "Comment prévenir l'isolement des patients ?\nQuelles mesures prendre pour des visites sûres ?", "url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=Matrix+Metalloproteinase+9#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Visiteurs des patients", "description": "Les visites font-elles partie du traitement ?\nComment les hôpitaux gèrent-ils les visites ?", "url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=Matrix+Metalloproteinase+9#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Visiteurs des patients", "description": "Quelles complications peuvent survenir sans visites ?\nLes visites peuvent-elles causer du stress au patient ?", "url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=Matrix+Metalloproteinase+9#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Visiteurs des patients", "description": "Quels facteurs augmentent le besoin de visites ?\nLes patients en soins intensifs ont-ils plus besoin de visites ?", "url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=Matrix+Metalloproteinase+9#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer l'impact des visites sur le patient ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'impact peut être évalué par des questionnaires sur le bien-être et l'état émotionnel." } }, { "@type": "Question", "name": "Quels signes indiquent qu'un patient a besoin de visites ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Un patient peut montrer des signes de solitude, d'anxiété ou de dépression." } }, { "@type": "Question", "name": "Quels symptômes peuvent s'aggraver sans visites ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "L'isolement social peut aggraver l'anxiété et la dépression chez le patient." } }, { "@type": "Question", "name": "Les visites peuvent-elles réduire la douleur perçue ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le soutien émotionnel des visiteurs peut diminuer la perception de la douleur." } }, { "@type": "Question", "name": "Comment prévenir l'isolement des patients ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Encourager les visites régulières et utiliser des technologies de communication." } }, { "@type": "Question", "name": "Quelles mesures prendre pour des visites sûres ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Respecter les protocoles d'hygiène et les restrictions de visite en place." } }, { "@type": "Question", "name": "Les visites font-elles partie du traitement ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les visites peuvent être considérées comme un complément au traitement médical." } }, { "@type": "Question", "name": "Comment les hôpitaux gèrent-ils les visites ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les hôpitaux établissent des horaires et des règles pour assurer la sécurité des patients." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir sans visites ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "L'absence de visites peut entraîner une détérioration de la santé mentale et physique." } }, { "@type": "Question", "name": "Les visites peuvent-elles causer du stress au patient ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des visites non planifiées ou trop fréquentes peuvent causer du stress." } }, { "@type": "Question", "name": "Quels facteurs augmentent le besoin de visites ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "L'âge avancé, les maladies chroniques et l'isolement social augmentent ce besoin." } }, { "@type": "Question", "name": "Les patients en soins intensifs ont-ils plus besoin de visites ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les patients en soins intensifs peuvent bénéficier davantage du soutien des visiteurs." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 26/03/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Samantha J Chiew

3 publications dans cette catégorie

Affiliations :
  • Animal Welfare Science Centre, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, North Melbourne, VIC, Australia.
Publications dans "Visiteurs des patients" :

Paul H Hemsworth

3 publications dans cette catégorie

Affiliations :
  • Animal Welfare Science Centre, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, North Melbourne, VIC, Australia.
Publications dans "Visiteurs des patients" :

Sally L Sherwen

3 publications dans cette catégorie

Affiliations :
  • Department of Wildlife Conservation and Science, Zoos Victoria, Parkville, VIC, Australia.
Publications dans "Visiteurs des patients" :

Grahame J Coleman

3 publications dans cette catégorie

Affiliations :
  • Animal Welfare Science Centre, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, North Melbourne, VIC, Australia.
Publications dans "Visiteurs des patients" :

Vicky Melfi

2 publications dans cette catégorie

Affiliations :
  • Hartpury University and Hartpury College, Gloucester, United Kingdom.
Publications dans "Visiteurs des patients" :

Yongchao Hou

2 publications dans cette catégorie

Affiliations :
  • Emergency Department, ShanXi Provincial People's Hospital, Taiyuan, ShanXi, China.
  • School of Nursing, Midwifery & Health Systems, University College Dublin, Dublin, Ireland.

Melissa Corbally

2 publications dans cette catégorie

Affiliations :
  • School of Nursing and Midwifery, Trinity College Dublin, Dublin, Ireland.

Fiona Timmins

2 publications dans cette catégorie

Affiliations :
  • School of Nursing, Midwifery & Health Systems, University College Dublin, Dublin, Ireland.

Jocelyn A Srigley

2 publications dans cette catégorie

Affiliations :
  • Department of Pathology and Laboratory Medicine, BC Children's Hospital, Vancouver, BC, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada. Electronic address: jocelyn.srigley@cw.bc.ca.

Amy Damashek

2 publications dans cette catégorie

Affiliations :
  • Western Michigan University, Kalamazoo, USA.
Publications dans "Visiteurs des patients" :

Emily A Vargas

1 publication dans cette catégorie

Affiliations :
  • Department of Psychology, University of Michigan, Ann Arbor, MI, USA.
  • Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Publications dans "Visiteurs des patients" :

Ramaswami Mahalingam

1 publication dans cette catégorie

Affiliations :
  • Department of Psychology, University of Michigan, Ann Arbor, MI, USA.
Publications dans "Visiteurs des patients" :

Riley A Marshall

1 publication dans cette catégorie

Affiliations :
  • Department of Psychology, University of Michigan, Ann Arbor, MI, USA.
Publications dans "Visiteurs des patients" :

Mark Otieno

1 publication dans cette catégorie

Affiliations :
  • Department of Animal Ecology and Tropical Biology, University of Würzburg, Würzburg, Germany.
  • Department of Agricultural Resource Management, University of Embu, Embu, Kenya.
Publications dans "Visiteurs des patients" :

Neelendra Joshi

1 publication dans cette catégorie

Affiliations :
  • Department of Entomology and Plant Pathology, University of Arkansas at Fayetteville, Fayetteville, AR, USA.
Publications dans "Visiteurs des patients" :

Benjamin Rutschmann

1 publication dans cette catégorie

Affiliations :
  • Department of Animal Ecology and Tropical Biology, University of Würzburg, Würzburg, Germany.
Publications dans "Visiteurs des patients" :

Audra N Iness

1 publication dans cette catégorie

Affiliations :
  • Division of Hematology, Oncology and Palliative Care, Massey Cancer Center, Virginia Commonwealth University, Richmond, Va; Department of Pediatrics, Baylor College of Medicine, Houston, Tex. Electronic address: audra.iness@bcm.edu.

Jefferson O Abaricia

1 publication dans cette catégorie

Affiliations :
  • Department of Bioengineering, College of Engineering, Virginia Commonwealth University, Richmond, Va.

Wendemi Sawadogo

1 publication dans cette catégorie

Affiliations :
  • Division of Epidemiology, Department of Family Medicine and Population Health, Virginia Commonwealth University, Richmond, Va.

Caleb M Iness

1 publication dans cette catégorie

Affiliations :
  • School of Medicine, California Northstate University, Elk Grove, Calif.

Sources (9918 au total)

Prognostic value of matrix metalloproteinase-2 protein and matrix metalloproteinase-9 protein in colorectal cancer: a meta-analysis.

Matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9) are critical components of the extracellular matrix (ECM) in colorectal cancer (CRC). We aimed to evaluate the prognostic valu... We performed a meta-analysis of cohort studies with available data on the effect of MMP-2 and MMP-9 expression on both disease-free survival (DFS) and overall survival (OS) by the risk ratios (RRs) wi... Eighteen trials were selected (Table 1) and included a total of 3944 patients. According to our primary meta-analysis, the expression of MMP-2 was significantly associated with a decrease in OS (RR = ... High MMP-2 expression, especially in cancer tissue, is significantly associated with both poor DFS and poor OS in patients with CRC. High MMP-9 expression tended to indicate a poor prognosis of CRC bu...

Expression of laminin-1 and matrix metalloproteinase-9 in benign and malignant endometrium.

Laminin-1 and matrix metalloproteinase (MMP)-9 may play roles in the progression from benign to malignant endometrium, so we aimed to investigate their levels of expression in these tissues.... This case-control study was conducted at a tertiary care center between January 2014 and December 2016. Paraffin blocks of 50 specimens of benign endometrium with proliferative (n = 20), secretory (n ... : Laminin-1 continuity in the basement membrane was higher in benign (92%) compared to malignant (16.3%) endometrium (p < 0.0001) without any difference between the subgroups within each group (p > 0.... Gradual increments in MMP-9 expression and basement membrane laminin-1 discontinuity may indicate progression from normal to hyperplastic and to low- and high-grade cancerous endometrium....

In Silico and In Vitro Approach for Validating the Inhibition of Matrix Metalloproteinase-9 by Quercetin.

To validate the mechanism and inhibitory activity of quercetin against matrix metalloproteinase-9 (MMP-9) using a hybrid in silico and in vitro approach.... The structure of MMP-9 was obtained from the Protein Data Bank, and the active site was identified using previous annotations from the Universal Protein Resource. The structure of quercetin was obtain... Quercetin interacts with MMP-9 by binding within the active site pocket and interacting with residues LEU 188, ALA 189, GLU 227, and MET 247. The binding affinity predicted by molecular docking was -9... Quercetin inhibited MMP-9 in a dose-dependent manner and was well-tolerated by HCECs, suggesting a potential role in therapy for diseases with upregulated MMP-9 as part of its pathogenesis....

Regulation of matrix metalloproteinase-9 during monopoiesis and zinc deficiency by chromatin remodeling.

Matrix metalloproteinase-9 (MMP-9) cleaves various extracellular matrix proteins, hence significantly contributes to numerous physiological but also pathological processes. Monocytic differentiation i... This study aims to find a correlation between zinc deficiency and MMP-9 transcriptional regulation, focusing on epigenetics as the possible mechanism behind zinc deficiency-induced changes.... The effect of differentiation and zinc deficiency on MMP-9 expression and MMP9 promoter accessibility was investigated using the acute promyelocytic cell line NB4. Intracellular free zinc levels were ... During monocytic differentiation of NB4 cells, the decrease in intracellular zinc levels was paralleled by an increased production of MMP-9. Assessment of chromatin structure revealed increased access... These data demonstrate an important role of epigenetic mechanisms in regulating MMP-9 expression under zinc deficiency. This could provide an encouraging step to expand the research on using zinc for ...

The expression of matrix metalloproteinase 2, 9 and 11 in Ethiopian breast cancer patients.

Matrix metalloproteinases (MMPs) play a pathophysiological role in cancer initiation and progression. Numerous studies have examined an association between MMP-2, MMP-9, and MMP-11 expression and clin... A total of 58 formalin-fixed paraffin-embedded breast tissue samples encompassing 16 benign breast tumors and 42 BC were collected. The RNA was extracted and quantitative reverse-transcription PCR was... The MMP-11 expression levels were significantly higher in breast cancer cases than in benign breast tumors (P = 0.012). Additionally, BC cases with positive lymph nodes and ER-positive receptors had h... The MMP-11 expression was higher in BC than in benign breast tumors. Additionally, MMP-11, MMP-9, and MMP-2 were higher in BC with positive lymph nodes and estrogen receptors. Our findings suggest an ...